Evidence map›Paper›PMID 33585699›Full record

ArticleOpen medicine (Warsaw, Poland)2021

miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway.

Lijuan Ke, Yanping Chen, Yiying Li, Zheng Chen, Yihui He, Jiahua Liu, Yingfeng Zhuang

Open access · goldAbstract read
In one paragraph

Article in Open medicine (Warsaw, Poland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Mechanistic studies ofFrontiers in oncology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Role and Dysregulation of miRNA in Patients with Parkinson's Disease.International journal of molecular sciences · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lijuan KeDepartment of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People's Republic of China.
Yanping ChenDepartment of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People's Republic of China.
Yiying LiDepartment of Gynecology and Obstetrics, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital South Branch, No. 516 Jinrong South Street, Fuzhou, Fujian 350028, People's Republic of China.
Zheng ChenDepartment of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People's Republic of China.
Yihui HeDepartment of Pathology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People's Republic of China.
Jiahua LiuDepartment of Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, No. 134 Dong Street, Fuzhou, Fujian 350001, People's Republic of China.
Yingfeng ZhuangDepartment of Critical Care Medicine, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital South Branch, No. 516 Jinrong South Street, Fuzhou, Fujian 350028, People's Republic of China.
Fujian Medical University · CNFujian Provincial Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious work has shown that miR-142-5p in cervical cancer tissues increased significantly compared with adjacent normal tissues. However, the function and the mechanism of miR-142-5p in cervical cancer have not been reported.

methodsQuantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to determine the gene expression levels. MTT, flow cytometry, and transwell assays were performed to explore the functions of miR-142-5p in HeLa cells. The potential target gene of miR-142-5p was investigated via luciferase reporter assays. The protein expression levels were analyzed by Western blotting.

resultsWe found that miR-142-5p expression was elevated but LIM homeobox transcription factor 1 alpha (LMX1A) was decreased in cervical cancer tissues and cells. Overexpression of miR-142-5p or knockdown of LMX1A inhibited cell apoptosis, promoted cell proliferation, migration, invasion abilities, and activated the Wnt/β-catenin pathway. However, knockdown of miR-142-5p or overexpression of LMX1A showed opposite results. LMX1A was identified as a direct target of miR-142-5p by luciferase reporter assays. Finally, rescue experiments demonstrated that LMX1A overexpression attenuated the carcinogenic effect of miR-142-5p mimic on HeLa cells.

conclusionsThese findings suggested that miR-142-5p might be a cervical cancer oncogene and could serve as a potential therapeutic target for the treatment of cervical cancer.

Indexed as

cervical cancerHeLa cellsLMX1AmiR-142-5pWnt/β-catenin pathway

Identifiers

PMID33585699
PMCPMC7862994
OpenAlexW3126855512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.